We've found
52,953 Cancer
clinical trials
Gastroenterology, Oncology Clinical Trial
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma (HCC) Clinical Trial
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma (HCC) Clinical Trial
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Physician Use of Non-English Language Skills in Cancer Care
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Status: Enrolling,
Phase
II
Updated: 11/24/2015
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Neratinib in Treating Older Patients With Metastatic HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Neratinib in Treating Older Patients With Metastatic HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Oncology Clinical Trial
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab in Subjects With Advanced GI Tumors (Keynote 596)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 2/15/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 2/15/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
I, II
Updated: 7/25/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
I, II
Updated: 7/25/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Cancers Clinical Trial
AGEN-1884, an Anti-CTLA-4 Antibody, in Advanced Solid Cancers
Status: Enrolling,
Phase
I
Updated: 5/1/2017
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, Dose-Escalation, Safety Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Randomized Trial of Recruitment Strategies for Research Participation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Randomized Trial of Recruitment Strategies for Research Participation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Randomized Trial of Recruitment Strategies for Research Participation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Status: Enrolling,
Phase
III
Updated: 5/22/2017
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Status: Enrolling,
Phase
III
Updated: 5/22/2017
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling,
Phase
II
Updated: 4/11/2018
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling,
Phase
II
Updated: 4/11/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Soft Tissue Sarcoma Clinical Trial
Stereotactic Radiosurgery for Soft Tissue Sarcoma
Status: Enrolling,
Phase
II
Updated: 3/7/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 2/13/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pleural Mesothelioma Clinical Trial
A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma
Status: Enrolling,
Phase
I
Updated: 1/2/2018
Click here to add this to my saved trials
Oncology Clinical Trial
LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
DHEA in Synovial Sarcoma Patients
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaplastic Thyroid Cancer Clinical Trial
Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
Status: Enrolling,
Phase
I
Updated: 8/18/2016
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Sapanisertib and Osimertinib in Treating Patients With Stage IV EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pink Warrior—Support Group Toolkit for Breast Cancer Survivors
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
52,953 Cancer
clinical trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma (HCC) Clinical Trial
Updated: 12/31/1969
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma (HCC) Clinical Trial
Updated: 12/31/1969
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Physician Use of Non-English Language Skills in Cancer Care
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
Updated: 7/29/2015
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
Updated: 7/29/2015
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
Updated: 7/29/2015
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
Updated: 7/29/2015
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 11/24/2015
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Status: Enrolling,
Phase
II
Updated: 11/24/2015
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Updated: 12/31/1969
Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Updated: 2/18/2016
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 12/31/1969
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Neratinib in Treating Older Patients With Metastatic HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Neratinib in Treating Older Patients With Metastatic HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Updated: 4/18/2018
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Updated: 4/18/2018
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab in Subjects With Advanced GI Tumors (Keynote 596)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Updated: 12/31/1969
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Updated: 12/31/1969
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Updated: 12/31/1969
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Updated: 12/31/1969
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/15/2018
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 2/15/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/15/2018
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 2/15/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/25/2017
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
I, II
Updated: 7/25/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/25/2017
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
I, II
Updated: 7/25/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Cancers Clinical Trial
Updated: 5/1/2017
AGEN-1884, an Anti-CTLA-4 Antibody, in Advanced Solid Cancers
Status: Enrolling,
Phase
I
Updated: 5/1/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
An Open-Label, Dose-Escalation, Safety Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Randomized Trial of Recruitment Strategies for Research Participation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Randomized Trial of Recruitment Strategies for Research Participation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Randomized Trial of Recruitment Strategies for Research Participation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 5/22/2017
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Status: Enrolling,
Phase
III
Updated: 5/22/2017
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 5/22/2017
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Status: Enrolling,
Phase
III
Updated: 5/22/2017
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 4/11/2018
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling,
Phase
II
Updated: 4/11/2018
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 4/11/2018
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling,
Phase
II
Updated: 4/11/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Soft Tissue Sarcoma Clinical Trial
Updated: 3/7/2016
Stereotactic Radiosurgery for Soft Tissue Sarcoma
Status: Enrolling,
Phase
II
Updated: 3/7/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/13/2018
Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 2/13/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pleural Mesothelioma Clinical Trial
Updated: 1/2/2018
A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma
Status: Enrolling,
Phase
I
Updated: 1/2/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Updated: 12/31/1969
Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
DHEA in Synovial Sarcoma Patients
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Updated: 12/31/1969
Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaplastic Thyroid Cancer Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 8/18/2016
Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
Status: Enrolling,
Phase
I
Updated: 8/18/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Sapanisertib and Osimertinib in Treating Patients With Stage IV EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/13/2018
Pink Warrior—Support Group Toolkit for Breast Cancer Survivors
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Updated: 10/27/2017
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Updated: 10/27/2017
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials